Danish drugmaker Novo Nordisk has bought a global licence for EpiDestiny’s sickle cell disease (SCD) programme, EPI01. EPI01 is a novel, orally available, disease-modifying therapy, comprised of a fixed-dose formulation of a DNA methyl-transferase enzyme […]
The charity says it has set the new taskforce on the back of analysis showing that the UK health system “will need to think differently to cope with the unique challenges presented by future dementia […]
Researchers have discovered a promising approach for treating triple-negative breast cancer by blocking an ‘addiction gene’ KIFC1. In a study funded by Breast Cancer Now and conducted by researchers from King’s College London and The […]
Having rejected the drug’s for relapsed or refractory classical Hodgkin lymphoma in adults unable to have an autologous stem cell transplant who failed treatment with brentuximab vedotin, the National Institute for Health and Care Excellence […]
French pharmaceutical company Sanofi Pasteur may seek US Food and Drug Administration (FDA) approval for its dengue vaccine Dengvaxia despite an ongoing legal battle and public outcry in the Philippines over reported deaths. Sanofi’s vaccine […]